Shenzhen Salubris Pharmaceuticals is a high-risk pharmaceutical company in China that specializes in developing and selling medical products for various health issues. With a focus on ESG, they offer a range of innovative drugs and medical devices for diseases like cardio-cerebral vascular disease, diabetes, and anti-tumor treatments. Operating globally, their business lines include high-end chemical drugs and orthopedic solutions.